Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/21/2003US6635468 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/21/2003US6635466 Adenovirus serotype 30 (Ad30)
10/21/2003US6635465 Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same
10/21/2003US6635462 Mutated form of arginine deiminase
10/21/2003US6635461 Encoded by isolated nucleic acid; has glycosyltransferase activity; given amino acid sequence; useful as diagnostic and therapeutic agent for cancer and thymus-related disorders
10/21/2003US6635459 Capable of remaining hybridized; use to increase production of lignans in plants which confer disease resistance and are used as anticancer agents and viricides
10/21/2003US6635454 DNA molecules coding for debranching enzymes derived from plants
10/21/2003US6635451 Conversion of dihomo-gamma linolenic acid (DGLA) to arachidonic acid and in the conversion of 20:4n-3 to eicosapentaenoic acid (EPA); Delta 6 desaturase and Delta 5 desaturase
10/21/2003US6635449 Exonuclease-mediated nucleic acid reassembly in directed evolution
10/21/2003US6635447 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
10/21/2003US6635441 Multi-sample fermentor and method of using same
10/21/2003US6635440 Method of isolation of RNA-binding compounds
10/21/2003US6635433 Methods and materials for diagnosing unstable angina
10/21/2003US6635431 Recombinant lipolysis stimulated (LSR) comprising polypeptide of given sequence; use for selecting a compound for enhancing lipoprotein uptake in cells expressing the polypeptide
10/21/2003US6635414 Apparatus for use in the preservation of pharmocological materials
10/21/2003US6635256 Administering multiple domain glycoprotein hormones containing alpha subunit covalently linked to beta subunit to form single chain hormone and additional beta subunit noncovalently linked to tethered alpha subunit of single chain hormone
10/21/2003US6635255 CASB414:antigen overexpressed in several tumors
10/21/2003US6635248 Isolated polypeptide consisting of single chain of amino acids comprising one or more penetrating fragments from one or more penetrating antibodies, which penetrates into cell
10/21/2003CA2294516C Ikk-.beta. proteins, nucleic acids and methods
10/21/2003CA2182289C Immuno-stimulatory monoclonal antibodies
10/21/2003CA2157659C Use of porcine gal .alpha. (1,3) galactosyl transferase in xenograft therapies
10/21/2003CA2132452C Casein kinase i-like protein kinase
10/21/2003CA2115049C Dna sequences encoding gelonin polypeptide
10/21/2003CA2106962C Polypeptides from mycobacterium paratuberculosis
10/21/2003CA2072649C Methods and materials for expression of human plasminogen variant
10/21/2003CA2066940C Canine coronavirus subunit vaccine
10/21/2003CA2017166C Metalloproteinase inhibitor
10/21/2003CA1341444C Modified tissue plasminogen activator
10/16/2003WO2003085405A1 Method for selecting bioactive agents by detecting variation induced in cyclic amp intracellular concentration of a sensitive living cell
10/16/2003WO2003085377A2 Novel pancortin-pablo protein interactions and methods of use thereof
10/16/2003WO2003085117A1 Viral vectors comprising a nucleic sequence derived from murine leukemia viruses for gene transfer in cells
10/16/2003WO2003085116A1 Lentiviral vectors derived from sivsmm/pbj14, method for their production and uses thereof
10/16/2003WO2003085106A1 Preventives and/or remedies for cancer
10/16/2003WO2003085105A1 A method for selecting cell lines to be used for nuclear transfer in mammalian species
10/16/2003WO2003085101A1 Automated bioculture and bioculture experiments system
10/16/2003WO2003085100A1 Method of culturing liver cells over long time
10/16/2003WO2003085099A2 A process for the preparation of stem cells from human muscle tissue and adipose tissue, and stem cells obtainable by this process
10/16/2003WO2003085095A2 Novel expressed genes
10/16/2003WO2003085092A2 Cellular transplantation for heart regeneration
10/16/2003WO2003085089A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
10/16/2003WO2003085086A2 Motif-grafted hybrid polypeptides and uses thereof
10/16/2003WO2003085079A1 Cell culture system, apparatus for checking cultured cells and apparatus for culturing cells
10/16/2003WO2003084998A1 Monoclonal antibody neutralizing megsin
10/16/2003WO2003084977A1 Gene expression control system and its use in recombinant virus packaging cell lines
10/16/2003WO2003084479A2 Large scale methods of producing adenovirus and adenovirus seed stocks
10/16/2003WO2003084478A2 Antisense modulation of hmgi-c expression
10/16/2003WO2003084468A2 Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof
10/16/2003WO2003084467A2 Epitope constructs comprising antigen presenting cell targeting mechanisms
10/16/2003WO2003084431A2 Method for growth of human conjunctival tissue equivalents for research, clinical ocular surface transplantation and tissue engineering
10/16/2003WO2003084385A2 Redifferentiated cells for repairing cartilage defects
10/16/2003WO2003084337A1 Triglyceride fat
10/16/2003WO2003084312A2 Identification and characterization of an anthocyanin mutant (ant1) in tomato
10/16/2003WO2003073238A3 Computational method for designing enzymes for incorporation of amino acid analogs into proteins
10/16/2003WO2003072707A3 Compositions comprising reproductive cell media and methods for using such compositions
10/16/2003WO2003070084A3 Artificial vessel scaffold and artificial organs therefrom
10/16/2003WO2003068813A3 Group b streptococcus antigen
10/16/2003WO2003065977A9 Modified antigen-presenting cells
10/16/2003WO2003064598A3 Serum-free media for chondrocytes and methods of use thereof
10/16/2003WO2003063792A8 Compositions and methods related to tim-3, a th1-specific cell surface molecule
10/16/2003WO2003062405A3 Method for inducing differentiation of embryonic stem cells
10/16/2003WO2003062276A3 Multimers of receptor-binding ligands
10/16/2003WO2003059282A3 Human monoclonal antibodies against cd30
10/16/2003WO2003057729A3 Mammal prolactin variants
10/16/2003WO2003057152A3 Hair follicle growth
10/16/2003WO2003056017A3 Alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said alkaline protease
10/16/2003WO2003054216A3 Antibodies that immunospecifically bind to trail receptors
10/16/2003WO2003048344A3 Differentiation of human embryonic stem cells in avian embryos
10/16/2003WO2003045335A3 Stem cell screening and transplantation therapy for hiv infection
10/16/2003WO2003042369A3 Cellular kinase targets and inhibitors, and methods for their use
10/16/2003WO2003042368A3 Methods of expressing lim mineralization protein in non-osseous cells
10/16/2003WO2003040316A3 Selective elimination of cd52+ cells and uses thereof
10/16/2003WO2003040298A3 Cell and tissue growth using substances that reversibly bind oxygen
10/16/2003WO2003039575A3 Use of reelin, gas6, and protein s in the treatment of neural disorders
10/16/2003WO2003038073A3 Method for enhancing keratinocyte stem cells
10/16/2003WO2003038062A3 Generation of use of tc1 and tc2 cells
10/16/2003WO2003037918A3 Pyranosone dehydratase from phanerochaete chrysosporium
10/16/2003WO2003035835A3 Glycoprotein compositions
10/16/2003WO2003035003A3 Fused cells, methods of forming same, and therapie utilizing same
10/16/2003WO2003033678A3 Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
10/16/2003WO2003031640A3 Preadipocyte cell strains and uses therefore
10/16/2003WO2003029434A3 Novel molecules of the hkid-1-related protein family and uses thereof
10/16/2003WO2003029426A3 Human and murine cytokine polypeptides
10/16/2003WO2003029413A3 A novel g protein-coupled receptor, gave 10
10/16/2003WO2003016496A3 Zinc finger binding domains for cnn
10/16/2003WO2003016488A3 Cell separation system
10/16/2003WO2003014359A3 A fusion protein
10/16/2003WO2003014320A3 Telomerase immortalized human neutral stem cells and phenotypically-restricted progenitor cells
10/16/2003WO2003014317A3 Compositions and methods for isolation, propagation, and differentiation of human stem cells and uses thereof
10/16/2003WO2003012394A3 Androgen receptor knock-out transgenic animals
10/16/2003WO2003006055A9 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit
10/16/2003WO2003002709A3 Novel technology for genetic mapping
10/16/2003WO2003000930A3 Nucleotide sequences involved in plant disease resistance
10/16/2003WO2002101018A3 Methods for inducing reversible stasis
10/16/2003WO2002098899A3 CHDs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
10/16/2003WO2002097043A3 Wnv core protein/capsid interacting protein and uses of the same
10/16/2003WO2002092024A3 Compounds and methods for inhibiting axillary malodour
10/16/2003WO2002090493A3 Δ4-desaturase genes and uses thereof
10/16/2003WO2002077211A3 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/16/2003WO2002070655A3 Mouse cytokine receptor
10/16/2003WO2002068677A8 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer